United Therapeutics Corporation (UTHR) Competitors & Peers
The 5 largest companies in the same industry as United Therapeutics Corporation, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| JHPCY | Peer | $12.25 | P/E 37.1RSI 35Cap 81.3 B |
| GDERF | Peer | $228.30 | P/E 62.5RSI 56Cap 50.8 B |
| TAK | Peer | $20.85 | P/E 297.9RSI 63Cap 66.5 B |
| GALDY | Peer | $45.65 | P/E 53.5RSI 46Cap 45.5 B |
| TKPHF | Peer | $42.77 | RSI 49Cap 59.7 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- LQDACompetitor
Liquidia's Yutrepia competes with United Therapeutics' Tyvaso.
Model-inferred, unverified — treat as a lead, not evidence - MNKDPartner
MNKD + UTHR Tyvaso DPI royalty.
Model-inferred, unverified — treat as a lead, not evidence